ClinicalTrials.Veeva

Menu

Comparison of Upper Extremity Function, Physical Activity Levels and Peripheral Muscle Strength, Fear of Movement, Balance, Activities of Daily Living and Quality of Life in Patients With Pacemakers According to Pacemaker Type

E

Erol Olcok Corum Training and Research Hospital

Status

Enrolling

Conditions

Cardiac Resynchronization Therapy
Pacemaker
Implantable Cardioverter Defibrillator

Study type

Observational

Funder types

Other

Identifiers

NCT06775691
2024-08/1

Details and patient eligibility

About

While research and clinical practice have demonstrated the objective benefits of pacemaker use on mortality, morbidity, and quality of life, some patients do not experience the expected level of improvement following device implantation. The purpose of this research was to determine the effects of device implantation on daily living activities, upper extremity functions, peripheral muscle strength, balance problems, fear of movement and quality of life.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least 3 months have passed since pacemaker implantation and there are no complications in the last pacemaker control,
  • Being in NYHA class I-II-III,
  • Patients with no coordination problems,
  • Volunteering to participate in the research

Exclusion criteria

  • Patients with a history of shoulder pathologies prior to pacemaker implantation that may restrict movement of the upper limb (conditions such as severe pain around the shoulder, edema or shoulder dislocation that may restrict upper limb movement),
  • Patients with a history of shoulder surgery (limitation in range of motion),
  • Patients who have had a cerebrovascular event resulting in mastectomy or arm involvement on the affected side,
  • Patients with decompensated heart failure,
  • Patients with a history of ICD inappropriate shock,
  • Those with acute myocardial infarction,
  • Patients with malignancy on active treatment, patients with collagen tissue disease receiving systemic steroids,
  • Chronic kidney disease patients on dialysis with unstable volume load

Trial design

60 participants in 3 patient groups

Group 1
Description:
Pacemaker - PM
Group 2
Description:
Implantable Cardioverter Defibrillator - ICD
Group 3
Description:
Cardiac Resynchronization Therapy - CRT

Trial contacts and locations

1

Loading...

Central trial contact

Gamze N AHISKALI, Master's degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems